Pre-order Enquiry
Download Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Market Analysis and Insights: Global Newcastle Disease Vaccine Market
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
Due to the COVID-19 pandemic, the global Newcastle Disease Vaccine market size is estimated to be worth US$ 314.8 million in 2022 and is forecast to a readjusted size of US$ 396.2 million by 2029 with a CAGR of 3.3% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Live Vaccines accounting for % of the Newcastle Disease Vaccine global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Chicken segment is altered to an % CAGR throughout this forecast period.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.
Global Newcastle Disease Vaccine Scope and Market Size
The global Newcastle Disease Vaccine market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Newcastle Disease Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Chicken
Duck & Goose
Other
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
Due to the COVID-19 pandemic, the global Newcastle Disease Vaccine market size is estimated to be worth US$ 314.8 million in 2022 and is forecast to a readjusted size of US$ 396.2 million by 2029 with a CAGR of 3.3% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Live Vaccines accounting for % of the Newcastle Disease Vaccine global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Chicken segment is altered to an % CAGR throughout this forecast period.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.
Global Newcastle Disease Vaccine Scope and Market Size
The global Newcastle Disease Vaccine market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Newcastle Disease Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Chicken
Duck & Goose
Other
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
